Avid Bioservices Inc (NASDAQ:CDMO) currently has a daily average trading volume of 846.98K but it saw 990351 shares traded in last market. With a market cap of 651.40M USD, the company’s current market price of $10.21 came falling about -1.45 while comparing to the previous closing price of $10.36. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.48 and as low as $4.07. In the recent trading on the day, stock has struck highest price mark of $9.985 while lowest mark touched by it was $10.46.
Taking a look at 20-day trading activity of Avid Bioservices Inc (CDMO) gives us an average price of $10.46, while its current price level is -18.19% below from 52-week high level whereas it is 150.83% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $10.61 while that of 200 days or SMA-200 reads an average of $8.47. A closer look into the stock’s movement over the week reveals that its volatility is standing at 4.08% during that period while stretching the period over a month that decreases to 3.83%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 45.49 which implies that the stock is in neutral territory.
KeyBanc Capital Markets upgraded its recommendation for the stock as a “Overweight” from “Sector Weight” on March 14, 2023 while assigning a price target of $20.
Over the week, CDMO’s stock price is moving 0.59% up while it is -4.85% when we observe its performance for the past one month. Year-to-date it is 57.08% up and over the past year, the stock is showing an upside performance of 44.62%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.15 beaten by the consensus estimate of -0.06 for the same. The company is expected to be releasing its next quarterly report in November, for which analysts forecasted an EPS of -0.12 while estimate for next year EPS is -0.29. In next quarter, company is expected to be making quarterly sales of $41.87M as analysts are expecting the sales for current fiscal year at $163.66M and seeing the company making $198.26M in sales next year. Moreover, analysts are in estimates of $33.8M for current-quarter revenue.
Currently, Avid Bioservices Inc’s total number of outstanding shares is 63.57M. Company’s return on investment (ROI) stands at -54.77% and return on equity (ROE) at -115.84%. Stock’s beta reads 1.39. Stock has a price to book (P/B) ratio of 11.11 while price to sale or P/S ratio amounts to 4.58. Its return on asset (ROA) is -37.08% on average.
